Total Payments
$619.51
2024 Payments
$90.74
Companies
12
Transactions
24
Medicare Patients
560
Medicare Billing
$72,266

Payment Breakdown by Category

Food & Beverage$619.51 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $619.51 24 100.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $162.46 3 $0 (2018)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $119.27 7 $0 (2024)
Gilead Sciences, Inc. $93.20 2 $0 (2021)
Alnylam Pharmaceuticals Inc. $42.47 2 $0 (2022)
E.R. Squibb & Sons, L.L.C. $38.73 2 $0 (2018)
ORPHALAN INC $30.07 1 $0 (2024)
QOL Medical, LLC $27.48 2 $0 (2023)
INTERCEPT PHARMACEUTICALS, INC. $25.88 1 $0 (2022)
Takeda Pharmaceuticals U.S.A., Inc. $22.36 1 $0 (2022)
Melinta Therapeutics, LLC $22.13 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $90.74 4 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($39.03)
2023 $63.43 4 QOL Medical, LLC ($27.48)
2022 $141.00 7 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($50.29)
2021 $40.39 2 Gilead Sciences, Inc. ($22.30)
2020 $82.76 2 Gilead Sciences, Inc. ($70.90)
2018 $201.19 5 Janssen Pharmaceuticals, Inc ($162.46)

All Payment Transactions

24 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/27/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.89 General
Category: Gastroenterology
10/18/2024 ORPHALAN INC CUVRIOR (Drug) Food and Beverage In-kind items and services $30.07 General
Category: Hepatology
10/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), PLENVU Food and Beverage In-kind items and services $17.14 General
Category: Gastroenterology
08/01/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $21.64 General
Category: Rare Disease
10/06/2023 Melinta Therapeutics, LLC Rezzayo (Drug), Kimyrsa, Vabomere Food and Beverage In-kind items and services $22.13 General
Category: ANTIFUNGALS
08/14/2023 QOL Medical, LLC Sucraid (Drug) Food and Beverage Cash or cash equivalent $15.61 General
Category: THERAPY FOR CSID
07/19/2023 QOL Medical, LLC Sucraid (Drug) Food and Beverage Cash or cash equivalent $11.87 General
Category: THERAPY FOR CSID
03/17/2023 Amgen Inc. AMJEVITA (Biological), AVSOLA Food and Beverage In-kind items and services $13.82 General
Category: Inflammation
12/01/2022 Alnylam Pharmaceuticals Inc. GIVLAARI (Drug) Food and Beverage In-kind items and services $13.13 General
Category: Genetic Disease
08/04/2022 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $22.36 General
Category: INTERNAL MEDICINE
08/02/2022 INTERCEPT PHARMACEUTICALS, INC. OCALIVA (Drug) Food and Beverage In-kind items and services $25.88 General
Category: Hepatology / Gastroenterology
07/21/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $22.05 General
Category: Gastroenterology
06/20/2022 Alnylam Pharmaceuticals Inc. GIVLAARI (Drug) Food and Beverage In-kind items and services $29.34 General
Category: Genetic Disease
04/13/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.07 General
Category: Gastroenterology
02/01/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.17 General
Category: Gastroenterology
10/26/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $18.09 General
Category: Gastroenterology
04/16/2021 Gilead Sciences, Inc. Food and Beverage In-kind items and services $22.30 General
12/07/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $11.86 General
Category: GASTROENTEROLOGY
09/23/2020 Gilead Sciences, Inc. Food and Beverage In-kind items and services $70.90 General
12/12/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $16.87 General
Category: Cardiovascular & Metabolism
12/06/2018 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $19.27 General
Category: Cardiovascular
11/30/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Cardiovascular & Metabolism
11/08/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $20.60 General
Category: Cardiovascular & Metabolism
09/27/2018 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $19.46 General
Category: Cardiovascular

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 177 241 $78,601 $19,846
2022 6 131 174 $55,116 $14,931
2021 8 201 349 $119,686 $31,655
2020 4 51 78 $22,400 $5,834
Total Patients
560
Total Services
842
Medicare Billing
$72,266
Procedure Codes
25

All Medicare Procedures & Services

25 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 53 68 $19,856 $5,013 25.2%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 23 50 $13,840 $3,673 26.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 28 30 $12,839 $3,628 28.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 17 17 $10,934 $2,618 23.9%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 25 27 $11,653 $2,147 18.4%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 16 33 $4,983 $1,557 31.2%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 15 16 $4,496 $1,211 26.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 57 75 $21,900 $6,185 28.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 19 19 $11,622 $3,110 26.8%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 14 31 $8,369 $2,095 25.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 15 16 $6,736 $1,965 29.2%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 15 22 $3,398 $824.42 24.3%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 11 11 $3,091 $751.93 24.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 35 162 $44,712 $10,946 24.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 32 41 $17,261 $4,550 26.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 45 52 $15,184 $4,448 29.3%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 17 17 $12,705 $3,524 27.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 17 17 $8,344 $2,466 29.6%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 18 19 $9,771 $2,275 23.3%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2021 21 21 $6,089 $2,072 34.0%
99238 Hospital discharge day management, 30 minutes or less Facility 2021 16 20 $5,620 $1,373 24.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 15 39 $10,608 $2,645 24.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 12 14 $5,678 $1,245 21.9%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2020 11 12 $2,498 $1,080 43.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 13 13 $3,616 $863.88 23.9%

About Dr. Bernard Partiula, D.O

Dr. Bernard Partiula, D.O is a Student in an Organized Health Care Education/Training Program healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2015. The National Provider Identifier (NPI) number assigned to this provider is 1417341645.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bernard Partiula, D.O has received a total of $619.51 in payments from pharmaceutical and medical device companies, with $90.74 received in 2024. These payments were reported across 24 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($619.51).

As a Medicare-enrolled provider, Partiula has provided services to 560 Medicare beneficiaries, totaling 842 services with total Medicare billing of $72,266. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.

Practice Information

Products in Payments

  • XARELTO (Drug) $162.46
  • XIFAXAN (Drug) $119.27
  • GIVLAARI (Drug) $42.47
  • ELIQUIS (Drug) $38.73
  • CUVRIOR (Drug) $30.07
  • Sucraid (Drug) $27.48
  • OCALIVA (Drug) $25.88
  • ENTYVIO (Biological) $22.36
  • Rezzayo (Drug) $22.13
  • IQIRVO (Drug) $21.64
  • AMJEVITA (Biological) $13.82

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Valhalla